ホーム>>Labeling & Detection>> Cyanine Dyes>>Sulfo-Cyanine7 NHS ester

Sulfo-Cyanine7 NHS ester

カタログ番号GC59188

Products are for research use only. Not for human use. We do not sell to patients.

Sulfo-Cyanine7 NHS ester 化学構造

Cas No.: 1603861-95-5 (potassium salt); 1604244-45-2 (inner salt)

サイズ 価格 在庫数 個数
1mg
$154.00
在庫あり
5mg
$406.00
在庫あり
25mg
$966.00
在庫あり
50mg
$1,778.00
在庫あり
100mg
$2,786.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Water soluble near infrared dye sulfo-Cyanine7, an amine-reactive succinimide ester.

Sulfo-Cyanine7 is an improved analog of Cy7® fluorophore with quantum yield improved by 20%, and higher photostability. This fluorescent dye is especially useful for NIR imaging.

Near infrared fluorescent imaging takes advantage of transparency of biological tissues at particular range of wavelengths. The method is non-destructive, and allows to monitor distribution of various labeled molecules in live organisms.

Sulfo-Cyanine7 NHS ester reagent allows to prepare sulfo-Cyanine7-labeled biomolecules, such as proteins, with ease. Dye labeled molecules can be subsequently used for various research and drug design related experiments.

This reagent has high water solubility, and is especially useful for the labeling of delicate proteins, and proteins prone to denaturation. Non-sulfonated Cyanine7 NHS ester soluble in organic phase is also available.

レビュー

Review for Sulfo-Cyanine7 NHS ester

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sulfo-Cyanine7 NHS ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.